WS4 Mepolizumab Exacerbation (MEX) study primary manuscript published in Lancet Respiratory Medicine
VIDEO: Prof. Heaney gives an overview of the WS1 Biomarker stratification study and the emerging results
Pivotal WS1 Biomarker Stratification study primary manuscript published in the Lancet Respiratory Medicine
Summary of the WS1 Biomarker Stratification study primary manuscript by the American Pharmacists Association
Manuscript published in European Respiratory Journal.
Editorial from: American Journal of Respiratory and Critical Care Medicine.
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique improve clinical decision making? A protocol for a randomised controlled trial using electronic monitoring.
A white paper describing RASP and how action is urgently needed to improve the prospects for people with severe asthma.
Asthma UK describes how action is urgently needed to improve the prospects for people with severe asthma.
Keep informed of the latest findings to emerge from RASP
Noting the contribution of RASP in understanding severe asthma.
Study offers hope for people with severe allergic asthma.
Examining the current status of novel treatments and research efforts to identify novel targets in the era of stratified medicines in severe asthma.
Description of the RASP study and it's aims.
Press release to announce the awarding of an MRC grant to RASP UK.
Asthma UK: Announcing the award of the grant funding by the MRC.